RHÖN-KLINIKUM AG / Key word(s): Final Results25.04.2013 / 07:00
Annual results 2012  Renewed increase in patients treated of 12.2 % is evidence of confidencein the quality of care and medical capability 9.0 % revenue growth in a challenging regulatory environment Growth driven by the integration of the HSK in Wiesbaden  42.9 % decline in earnings, mainly due to setbacks in the UKGMrestructuring and other non-recurring chargesResults of Q1 2013 Increase of 60,781 or 10.0 % in number of patients to a total of 670,677cases underlines a good start to the new financial year Revenue grows by 10.2 % to EUR752.2 million Consolidated net profit decreases by EUR9.8 million or 28.7 % to EUR24.3million EBIT falls by EUR8.6 million or 17.7 % to EUR39.9 million EBITDA shrinks by EUR6.9 million or 8.4 % to EUR74.9 millionIn 2012, nearly 2.6 million patients were treated in the Group's hospitals.In the same period, revenue rose to EUR2.86 billion. Due to setbacks in therestructuring of the University Hospital Gießen and Marburg (UKGM),non-recurring charges connected to the Fresenius takeover bid, increasedregulatory pressure and a negative contribution from Dr. Horst SchmidtKliniken Wiesbaden (HSK), which was consolidated for the first time in2012, consolidated net profit fell 42.9 % to EUR92.0 million. EBITDA,adjusted for the effect of the Siemens compensation payment with regard to'PTZ Marburg' in the 2011 financial year, declined by 13.7 % to EUR291.5million year-on-year, and EBIT fell 29.5 % to EUR150.3 million.'Despite the eventful and difficult 2012 financial year, RHÖN-KLINIKUM AG'srevenue and patient numbers are rising steadily. The continuingattractiveness of our services is clearly strengthened by this show ofconfidence. Nonetheless, the cost situation overall is unsatisfactory,'said Dr Martin Siebert, Chairman of the Board of Management atRHÖN-KLINIKUM AG.At this year's Annual General Meeting on 12 June 2013, the Board ofManagement and Supervisory Board will propose a dividend distribution ofEUR0.25 (previous year: EUR0.45) per share entitled to dividend (DE0007042301; 138,232,000 shares).Jobs 2012As of 31 December 2012, RHÖN-KLINIKUM AG employed 43,059 people in tenGerman states. That is once again more than the year before. In manyregions, the hospitals of the RHÖN-KLINIKUM Group are among the largestemployers.Results of Q1 2013670,677 patients were treated in the first three months of the currentfinancial year (+10.0 %). Revenue grew to EUR752.2 million (+10.2 %).Consolidated net profit fell by 28.7 % to EUR24.3 million. EBITDA decreasedto EUR74.9 million (-8.4 %). EBIT declined to EUR39.9 million and is thus17.7 % lower than in the previous year.Outlook for 2013The company has confirmed its forecast for 2013 as a whole. In 2013,RHÖN-KLINIKUM AG expects revenue of EUR3.03 billion, plus or minus 2.5 %.This revenue target is accompanied by an EBITDA forecast of EUR325 millionand a consolidated net profit forecast of EUR110 million, each with afluctuation range of +/- 5 %.'We are confident that the structural, procedural and staffing measures ofrecent months have laid the first important foundations for making thecompany more competitive, so that RHÖN-KLINIKUM AG can return to where webelieve it belongs: at the very top of the market. The institutional basisfor this will be provided by a systematic Group-wide optimisationprogramme, currently being launched, which relates to our traditionalstrengths and also enriches our tried-and-tested business model with freshstimulus,' said Dr Martin Siebert, Chairman of the Board of Management atRHÖN-KLINIKUM AG.'The goal is clear: step by step, we want to rebuild the company as anintegrated health group, in which knowledge, skills, technologies andprocesses are first and foremost systematically shared and closelyinterlinked to a much greater degree than before. In the future, astrengthened University Hospital Gießen and Marburg will play a moreimportant role as a 'medical technology hub' for all Group hospitals,' theBoard of Management Chairman said.Wiesbaden's Dr. Horst Schmidt Kliniken (HSK) is being integrated into thecompany 'energetically': 'We are on budget and expect to achieve the firstpositive monthly results in the third quarter of this year. Achieving ourprofitability targets is therefore not an end in itself, but rather thenecessary financial requirement not only to uphold our long-held credo ofaffordable top-quality medical care for everyone, but also to improve onit,' said Siebert.End of Corporate News
25.04.2013 Dissemination of a Corporate News, transmitted by DGAP - acompany of EquityStory AG.The issuer is solely responsible for the content of this announcement.DGAP's Distribution Services include Regulatory Announcements,Financial/Corporate News and Press Releases.Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: rka@rhoen-klinikum-ag.com Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service 
 208463 25.04.2013